vTv Therapeutics (VTVT) Net Shares Issued and Repurchased (2015 - 2022)

vTv Therapeutics has disclosed Net Shares Issued and Repurchased across 8 years of filings, most recently posting $2.5 million for Q1 2022.

• In Q1 2022, Net Shares Issued and Repurchased rose 8909.97% year-over-year to $2.5 million; the TTM figure through Mar 2022 stood at $2.5 million (up 8909.97% YoY), while the FY2021 annual figure was $3.4 million, up 70.54% from the prior year.
• Net Shares Issued and Repurchased came in at $2.5 million for Q1 2022 at vTv Therapeutics, down from $3.4 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $3.4 million in Q4 2021 to a low of $28121.0 in Q1 2021.
• Average Net Shares Issued and Repurchased over 5 years is $1.3 million, with a median of $990750.0 recorded in 2019.
• Year-over-year, Net Shares Issued and Repurchased slumped 96.35% in 2018 and jumped 8909.97% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $295979.0 in 2018, then jumped by 249.01% to $1.0 million in 2019, then soared by 91.21% to $2.0 million in 2020, then jumped by 70.54% to $3.4 million in 2021, then declined by 24.79% to $2.5 million in 2022.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $2.5 million in Q1 2022, $3.4 million in Q4 2021, and $28121.0 in Q1 2021.